Lumenis M22
IPL multi-app platform · Universal IPL w/ ExpertFilters + ResurFX + Q-YAG
New Lumenis M22 pricing is not published; used and refurbished systems trade around $25k–$50k. Lumenis M22 holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: Multi-application IPL/Nd:YAG platform: hair removal, vascular/pigmented lesions, photorejuvenation
Last verified: August 6, 2026 · How we verify
New: —|Used: $25k–$50kmarket estimate, no email required
| Manufacturer | Lumenis |
|---|---|
| Company | Owner: Baring Private Equity Asia (BPEA, now part of EQT) (private equity owned, since 2019) · Distribution: direct |
| Category | Hair Removal & IPL |
| Technology | Universal IPL w/ ExpertFilters + ResurFX + Q-YAG |
| FDA status | FDA Cleared |
| New price range | Not published |
| Used price range | $25k–$50k |
| Consumables | Not published |
| Launch year | 2010 |
| Last verified | August 6, 2026 |
Bottom line
The dominant medspa IPL platform of the 2010s is now the best value in used light-based devices: $25k-50k buys the same Universal IPL physics as a $100k+ Stellar, with the deepest clinical paper trail in the IPL category. The killer feature for a used buyer is ResurFX — non-ablative fractional with no per-treatment consumable, so your entire menu runs on lamps and lightguides. The trap is configuration: modules are factory-installed and licensed, so the machine you buy is the machine you'll own — adding ResurFX later via Lumenis is somewhere between expensive and impossible. Buy fully configured or don't bother.
Overview
Dominant med-spa IPL of the 2010s
How it works
The science
Multi-application platform hosting up to four modules: Universal IPL (515-1200nm with snap-in cutoff filters) for sun damage, rosacea, telangiectasias, photoaging; ResurFX (1565nm fractional fiber) creating microscopic dermal coagulation columns for texture, pores, acne scars, striae; multi-spot long-pulse Nd:YAG for leg veins; Q-switched Nd:YAG for pigment. Optimal Pulse Technology delivers square, flat-topped pulses so energy doesn't spike mid-pulse — the core reason M22 IPL burns less and treats more consistently than commodity IPLs. Photofractional (same-day IPL + ResurFX) remains a $650-1,200 ticket, and the dry-eye/MGD crossover keeps ophthalmology demand for used units strong.
Patented tech
Optimal Pulse Technology — capacitor-controlled square-pulse IPL delivery — and ExpertFilters: nine interchangeable wavelength filters (including dual-band vascular) retuning one handpiece across targets and skin types.
Origin
Lumenis (Lumenis Be), Yokneam, Israel.
FDA & regulatory status
What it's actually cleared for:
Multi-application IPL/Nd:YAG platform: hair removal, vascular/pigmented lesions, photorejuvenation
510(k) numbers
K142860
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Lumenis that can affect warranty, service and parts availability.
- Sep 2021
Boston Scientific acquires Lumenis surgical unit for $1.07B
DivestitureBoston Scientific acquired the Lumenis surgical/urology business for $1.07B upfront, announced March 3, 2021 and closed September 1, 2021. The aesthetics and ophthalmology businesses were retained by Baring Private Equity Asia and operate as Lumenis Be Ltd.
Source: Boston Scientific and BPEA press releases
Treatment economics
What practices charge
IPL photofacials $350-600 (3-packs $900-1,500); ResurFX $500-1,000; Photofractional $650-1,200; vascular/pigment spots $150-400. A configured used M22 doing 15 IPLs a week grosses its purchase price back in roughly a quarter.
Consumables & recurring cost
No tips, no cards, no lockouts — the honest consumable profile that makes this the anti-Thermage of used buys. Real costs: IPL flashlamps (finite shot life — check counters), sapphire lightguides that crack ($1k-3k), filters that last years — $1,500-4,000/year busy. Buyer diligence is lamp count and lightguide condition, not credit balances.
Ideal for
Best-fit practice
A general medspa or derm practice with broad photoaging demand (Fitzpatrick I-IV, the 35-65 demographic) wanting four revenue streams from one footprint — or an ophthalmology practice building a dry-eye IPL line. Wrong buy stripped-down: an IPL-only M22 competes with much cheaper devices, so pay up for ResurFX-included units.
Compliance
Medical director & delegation
Class II prescription device; IPL and non-ablative fractional delegable to RNs and, in some states, aestheticians under supervising physicians with standing orders.
Contraindications & screening
Recent tanning (the classic IPL burn scenario), isotretinoin within 6 months, photosensitizers, pregnancy, active infection or suspicious lesions in-field; Fitzpatrick V-VI high PIH risk for IPL; ResurFX safer in darker types at conservative settings.
Ownership
Warranty & service
Deep third-party support — possibly the easiest legacy platform in aesthetics to keep alive; failure points are lamp sockets, lightguides, water pumps, occasional module boards. Lumenis still supports the family but prioritizes Stellar; $3k-6k/year third-party realistic.
Resale & used market
$25k-50k by module count and lamp life, among the most liquid used devices in the industry; easing slowly as Stellar units hit the secondary market, but a ResurFX-equipped M22 stays sellable for years.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
Warranty & service
Deep third-party support — possibly the easiest legacy platform in aesthetics to keep alive; failure points are lamp sockets, lightguides, water pumps, occasional module boards. Lumenis still supports the family but prioritizes Stellar; $3k-6k/year third-party realistic.
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.